OppenheimerFunds Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$803M |
| 2 |
Alibaba
BABA
|
+$375M |
| 3 |
Nektar Therapeutics
NKTR
|
+$213M |
| 4 |
Meta Platforms (Facebook)
META
|
+$209M |
| 5 |
SLB Ltd
SLB
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.01B |
| 2 |
New Oriental
EDU
|
+$317M |
| 3 |
Comcast
CMCSA
|
+$241M |
| 4 |
Intercontinental Exchange
ICE
|
+$238M |
| 5 |
DaVita
DVA
|
+$203M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.28% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 13.72% |
| 4 | Energy | 13.45% |
| 5 | Financials | 13.43% |
Similar funds
OppenheimerFunds's Q4 2018 Portfolio in Review
As of Q4 2018, OppenheimerFunds held 1,919 positions worth $70.1B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds withdrew a net $2.27B in Q4 2018, closing 131 positions and reducing 712 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.01B position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, OppenheimerFunds opened a new position in Caesars Entertainment Corporation worth $68.1M.
- OppenheimerFunds's largest Q4 2018 buy was Caesars Entertainment Corporation: 10,035,079 shares worth $68.1M.
- OppenheimerFunds added most to Energy Transfer Partners in Q4 2018, an estimated $803M increase.
- OppenheimerFunds's biggest Q4 2018 reduction was New Oriental, cutting an estimated $317M.
- OppenheimerFunds fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.01B.
- OppenheimerFunds's ten largest holdings make up 17% of its $70.1B portfolio in Q4 2018.
- OppenheimerFunds opened 109 new positions and closed 131 in Q4 2018.
- OppenheimerFunds's portfolio value fell 19% quarter-over-quarter to $70.1B.
Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.